Request for Covid-19 Impact Assessment of this Report
The United States Human Rabies Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Human Rabies Vaccines market, reaching US$ million by the year 2028. As for the Europe Human Rabies Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Human Rabies Vaccines players cover Sanofi Pasteur,Inc., Novartis Vaccines and Diagnostics Ltd., Cadila Pharmaceuticals Ltd., and GlaxoSmithKline Biologicals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Rabies Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Pre-Exposure Prophylaxis
Post-Exposure Prophylaxis
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Sanofi Pasteur,Inc.
Novartis Vaccines and Diagnostics Ltd.
Cadila Pharmaceuticals Ltd.
GlaxoSmithKline Biologicals
Merck&Co Inc.
Wyeth pharmaceuticals
Berna Biotech Ltd.
Medimmune LLC
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Rabies Vaccines Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Human Rabies Vaccines by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Human Rabies Vaccines by Country/Region, 2017, 2022 & 2028
2.2 Human Rabies Vaccines Segment by Type
2.2.1 Vero Cell Rabies Vaccine
2.2.2 BHK
2.2.3 Chick Embryo Cell Rabies Vaccine
2.2.4 Others
2.3 Human Rabies Vaccines Sales by Type
2.3.1 Global Human Rabies Vaccines Sales Market Share by Type (2017-2022)
2.3.2 Global Human Rabies Vaccines Revenue and Market Share by Type (2017-2022)
2.3.3 Global Human Rabies Vaccines Sale Price by Type (2017-2022)
2.4 Human Rabies Vaccines Segment by Application
2.4.1 Pre-Exposure Prophylaxis
2.4.2 Post-Exposure Prophylaxis
2.5 Human Rabies Vaccines Sales by Application
2.5.1 Global Human Rabies Vaccines Sale Market Share by Application (2017-2022)
2.5.2 Global Human Rabies Vaccines Revenue and Market Share by Application (2017-2022)
2.5.3 Global Human Rabies Vaccines Sale Price by Application (2017-2022)
3 Global Human Rabies Vaccines by Company
3.1 Global Human Rabies Vaccines Breakdown Data by Company
3.1.1 Global Human Rabies Vaccines Annual Sales by Company (2020-2022)
3.1.2 Global Human Rabies Vaccines Sales Market Share by Company (2020-2022)
3.2 Global Human Rabies Vaccines Annual Revenue by Company (2020-2022)
3.2.1 Global Human Rabies Vaccines Revenue by Company (2020-2022)
3.2.2 Global Human Rabies Vaccines Revenue Market Share by Company (2020-2022)
3.3 Global Human Rabies Vaccines Sale Price by Company
3.4 Key Manufacturers Human Rabies Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Rabies Vaccines Product Location Distribution
3.4.2 Players Human Rabies Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Human Rabies Vaccines by Geographic Region
4.1 World Historic Human Rabies Vaccines Market Size by Geographic Region (2017-2022)
4.1.1 Global Human Rabies Vaccines Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Human Rabies Vaccines Annual Revenue by Geographic Region
4.2 World Historic Human Rabies Vaccines Market Size by Country/Region (2017-2022)
4.2.1 Global Human Rabies Vaccines Annual Sales by Country/Region (2017-2022)
4.2.2 Global Human Rabies Vaccines Annual Revenue by Country/Region
4.3 Americas Human Rabies Vaccines Sales Growth
4.4 APAC Human Rabies Vaccines Sales Growth
4.5 Europe Human Rabies Vaccines Sales Growth
4.6 Middle East & Africa Human Rabies Vaccines Sales Growth
5 Americas
5.1 Americas Human Rabies Vaccines Sales by Country
5.1.1 Americas Human Rabies Vaccines Sales by Country (2017-2022)
5.1.2 Americas Human Rabies Vaccines Revenue by Country (2017-2022)
5.2 Americas Human Rabies Vaccines Sales by Type
5.3 Americas Human Rabies Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Rabies Vaccines Sales by Region
6.1.1 APAC Human Rabies Vaccines Sales by Region (2017-2022)
6.1.2 APAC Human Rabies Vaccines Revenue by Region (2017-2022)
6.2 APAC Human Rabies Vaccines Sales by Type
6.3 APAC Human Rabies Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Human Rabies Vaccines by Country
7.1.1 Europe Human Rabies Vaccines Sales by Country (2017-2022)
7.1.2 Europe Human Rabies Vaccines Revenue by Country (2017-2022)
7.2 Europe Human Rabies Vaccines Sales by Type
7.3 Europe Human Rabies Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Rabies Vaccines by Country
8.1.1 Middle East & Africa Human Rabies Vaccines Sales by Country (2017-2022)
8.1.2 Middle East & Africa Human Rabies Vaccines Revenue by Country (2017-2022)
8.2 Middle East & Africa Human Rabies Vaccines Sales by Type
8.3 Middle East & Africa Human Rabies Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Rabies Vaccines
10.3 Manufacturing Process Analysis of Human Rabies Vaccines
10.4 Industry Chain Structure of Human Rabies Vaccines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Rabies Vaccines Distributors
11.3 Human Rabies Vaccines Customer
12 World Forecast Review for Human Rabies Vaccines by Geographic Region
12.1 Global Human Rabies Vaccines Market Size Forecast by Region
12.1.1 Global Human Rabies Vaccines Forecast by Region (2023-2028)
12.1.2 Global Human Rabies Vaccines Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Rabies Vaccines Forecast by Type
12.7 Global Human Rabies Vaccines Forecast by Application
13 Key Players Analysis
13.1 Sanofi Pasteur,Inc.
13.1.1 Sanofi Pasteur,Inc. Company Information
13.1.2 Sanofi Pasteur,Inc. Human Rabies Vaccines Product Offered
13.1.3 Sanofi Pasteur,Inc. Human Rabies Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sanofi Pasteur,Inc. Main Business Overview
13.1.5 Sanofi Pasteur,Inc. Latest Developments
13.2 Novartis Vaccines and Diagnostics Ltd.
13.2.1 Novartis Vaccines and Diagnostics Ltd. Company Information
13.2.2 Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Product Offered
13.2.3 Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Novartis Vaccines and Diagnostics Ltd. Main Business Overview
13.2.5 Novartis Vaccines and Diagnostics Ltd. Latest Developments
13.3 Cadila Pharmaceuticals Ltd.
13.3.1 Cadila Pharmaceuticals Ltd. Company Information
13.3.2 Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Product Offered
13.3.3 Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Cadila Pharmaceuticals Ltd. Main Business Overview
13.3.5 Cadila Pharmaceuticals Ltd. Latest Developments
13.4 GlaxoSmithKline Biologicals
13.4.1 GlaxoSmithKline Biologicals Company Information
13.4.2 GlaxoSmithKline Biologicals Human Rabies Vaccines Product Offered
13.4.3 GlaxoSmithKline Biologicals Human Rabies Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 GlaxoSmithKline Biologicals Main Business Overview
13.4.5 GlaxoSmithKline Biologicals Latest Developments
13.5 Merck&Co Inc.
13.5.1 Merck&Co Inc. Company Information
13.5.2 Merck&Co Inc. Human Rabies Vaccines Product Offered
13.5.3 Merck&Co Inc. Human Rabies Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Merck&Co Inc. Main Business Overview
13.5.5 Merck&Co Inc. Latest Developments
13.6 Wyeth pharmaceuticals
13.6.1 Wyeth pharmaceuticals Company Information
13.6.2 Wyeth pharmaceuticals Human Rabies Vaccines Product Offered
13.6.3 Wyeth pharmaceuticals Human Rabies Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Wyeth pharmaceuticals Main Business Overview
13.6.5 Wyeth pharmaceuticals Latest Developments
13.7 Berna Biotech Ltd.
13.7.1 Berna Biotech Ltd. Company Information
13.7.2 Berna Biotech Ltd. Human Rabies Vaccines Product Offered
13.7.3 Berna Biotech Ltd. Human Rabies Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Berna Biotech Ltd. Main Business Overview
13.7.5 Berna Biotech Ltd. Latest Developments
13.8 Medimmune LLC
13.8.1 Medimmune LLC Company Information
13.8.2 Medimmune LLC Human Rabies Vaccines Product Offered
13.8.3 Medimmune LLC Human Rabies Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Medimmune LLC Main Business Overview
13.8.5 Medimmune LLC Latest Developments
14 Research Findings and Conclusion
Table 1. Human Rabies Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Human Rabies Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Vero Cell Rabies Vaccine
Table 4. Major Players of BHK
Table 5. Major Players of Chick Embryo Cell Rabies Vaccine
Table 6. Major Players of Others
Table 7. Global Human Rabies Vaccines Sales by Type (2017-2022) & (K Units)
Table 8. Global Human Rabies Vaccines Sales Market Share by Type (2017-2022)
Table 9. Global Human Rabies Vaccines Revenue by Type (2017-2022) & ($ million)
Table 10. Global Human Rabies Vaccines Revenue Market Share by Type (2017-2022)
Table 11. Global Human Rabies Vaccines Sale Price by Type (2017-2022) & (USD/Unit)
Table 12. Global Human Rabies Vaccines Sales by Application (2017-2022) & (K Units)
Table 13. Global Human Rabies Vaccines Sales Market Share by Application (2017-2022)
Table 14. Global Human Rabies Vaccines Revenue by Application (2017-2022)
Table 15. Global Human Rabies Vaccines Revenue Market Share by Application (2017-2022)
Table 16. Global Human Rabies Vaccines Sale Price by Application (2017-2022) & (USD/Unit)
Table 17. Global Human Rabies Vaccines Sales by Company (2020-2022) & (K Units)
Table 18. Global Human Rabies Vaccines Sales Market Share by Company (2020-2022)
Table 19. Global Human Rabies Vaccines Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Human Rabies Vaccines Revenue Market Share by Company (2020-2022)
Table 21. Global Human Rabies Vaccines Sale Price by Company (2020-2022) & (USD/Unit)
Table 22. Key Manufacturers Human Rabies Vaccines Producing Area Distribution and Sales Area
Table 23. Players Human Rabies Vaccines Products Offered
Table 24. Human Rabies Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Human Rabies Vaccines Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Human Rabies Vaccines Sales Market Share Geographic Region (2017-2022)
Table 29. Global Human Rabies Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Human Rabies Vaccines Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Human Rabies Vaccines Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Human Rabies Vaccines Sales Market Share by Country/Region (2017-2022)
Table 33. Global Human Rabies Vaccines Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Human Rabies Vaccines Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Human Rabies Vaccines Sales by Country (2017-2022) & (K Units)
Table 36. Americas Human Rabies Vaccines Sales Market Share by Country (2017-2022)
Table 37. Americas Human Rabies Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Human Rabies Vaccines Revenue Market Share by Country (2017-2022)
Table 39. Americas Human Rabies Vaccines Sales by Type (2017-2022) & (K Units)
Table 40. Americas Human Rabies Vaccines Sales Market Share by Type (2017-2022)
Table 41. Americas Human Rabies Vaccines Sales by Application (2017-2022) & (K Units)
Table 42. Americas Human Rabies Vaccines Sales Market Share by Application (2017-2022)
Table 43. APAC Human Rabies Vaccines Sales by Region (2017-2022) & (K Units)
Table 44. APAC Human Rabies Vaccines Sales Market Share by Region (2017-2022)
Table 45. APAC Human Rabies Vaccines Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Human Rabies Vaccines Revenue Market Share by Region (2017-2022)
Table 47. APAC Human Rabies Vaccines Sales by Type (2017-2022) & (K Units)
Table 48. APAC Human Rabies Vaccines Sales Market Share by Type (2017-2022)
Table 49. APAC Human Rabies Vaccines Sales by Application (2017-2022) & (K Units)
Table 50. APAC Human Rabies Vaccines Sales Market Share by Application (2017-2022)
Table 51. Europe Human Rabies Vaccines Sales by Country (2017-2022) & (K Units)
Table 52. Europe Human Rabies Vaccines Sales Market Share by Country (2017-2022)
Table 53. Europe Human Rabies Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Human Rabies Vaccines Revenue Market Share by Country (2017-2022)
Table 55. Europe Human Rabies Vaccines Sales by Type (2017-2022) & (K Units)
Table 56. Europe Human Rabies Vaccines Sales Market Share by Type (2017-2022)
Table 57. Europe Human Rabies Vaccines Sales by Application (2017-2022) & (K Units)
Table 58. Europe Human Rabies Vaccines Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Human Rabies Vaccines Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Human Rabies Vaccines Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Human Rabies Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Human Rabies Vaccines Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Human Rabies Vaccines Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Human Rabies Vaccines Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Human Rabies Vaccines Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Human Rabies Vaccines Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Human Rabies Vaccines
Table 68. Key Market Challenges & Risks of Human Rabies Vaccines
Table 69. Key Industry Trends of Human Rabies Vaccines
Table 70. Human Rabies Vaccines Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Human Rabies Vaccines Distributors List
Table 73. Human Rabies Vaccines Customer List
Table 74. Global Human Rabies Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Human Rabies Vaccines Sales Market Forecast by Region
Table 76. Global Human Rabies Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Human Rabies Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Human Rabies Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Human Rabies Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Human Rabies Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Human Rabies Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Human Rabies Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Human Rabies Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Human Rabies Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Human Rabies Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Human Rabies Vaccines Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Human Rabies Vaccines Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Human Rabies Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Human Rabies Vaccines Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Human Rabies Vaccines Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Human Rabies Vaccines Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Human Rabies Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Human Rabies Vaccines Revenue Market Share Forecast by Application (2023-2028)
Table 94. Sanofi Pasteur,Inc. Basic Information, Human Rabies Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 95. Sanofi Pasteur,Inc. Human Rabies Vaccines Product Offered
Table 96. Sanofi Pasteur,Inc. Human Rabies Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 97. Sanofi Pasteur,Inc. Main Business
Table 98. Sanofi Pasteur,Inc. Latest Developments
Table 99. Novartis Vaccines and Diagnostics Ltd. Basic Information, Human Rabies Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 100. Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Product Offered
Table 101. Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 102. Novartis Vaccines and Diagnostics Ltd. Main Business
Table 103. Novartis Vaccines and Diagnostics Ltd. Latest Developments
Table 104. Cadila Pharmaceuticals Ltd. Basic Information, Human Rabies Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 105. Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Product Offered
Table 106. Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 107. Cadila Pharmaceuticals Ltd. Main Business
Table 108. Cadila Pharmaceuticals Ltd. Latest Developments
Table 109. GlaxoSmithKline Biologicals Basic Information, Human Rabies Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 110. GlaxoSmithKline Biologicals Human Rabies Vaccines Product Offered
Table 111. GlaxoSmithKline Biologicals Human Rabies Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 112. GlaxoSmithKline Biologicals Main Business
Table 113. GlaxoSmithKline Biologicals Latest Developments
Table 114. Merck&Co Inc. Basic Information, Human Rabies Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 115. Merck&Co Inc. Human Rabies Vaccines Product Offered
Table 116. Merck&Co Inc. Human Rabies Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 117. Merck&Co Inc. Main Business
Table 118. Merck&Co Inc. Latest Developments
Table 119. Wyeth pharmaceuticals Basic Information, Human Rabies Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 120. Wyeth pharmaceuticals Human Rabies Vaccines Product Offered
Table 121. Wyeth pharmaceuticals Human Rabies Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 122. Wyeth pharmaceuticals Main Business
Table 123. Wyeth pharmaceuticals Latest Developments
Table 124. Berna Biotech Ltd. Basic Information, Human Rabies Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 125. Berna Biotech Ltd. Human Rabies Vaccines Product Offered
Table 126. Berna Biotech Ltd. Human Rabies Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 127. Berna Biotech Ltd. Main Business
Table 128. Berna Biotech Ltd. Latest Developments
Table 129. Medimmune LLC Basic Information, Human Rabies Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 130. Medimmune LLC Human Rabies Vaccines Product Offered
Table 131. Medimmune LLC Human Rabies Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 132. Medimmune LLC Main Business
Table 133. Medimmune LLC Latest Developments
List of Figures
Figure 1. Picture of Human Rabies Vaccines
Figure 2. Human Rabies Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Rabies Vaccines Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Human Rabies Vaccines Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Human Rabies Vaccines Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Vero Cell Rabies Vaccine
Figure 10. Product Picture of BHK
Figure 11. Product Picture of Chick Embryo Cell Rabies Vaccine
Figure 12. Product Picture of Others
Figure 13. Global Human Rabies Vaccines Sales Market Share by Type in 2021
Figure 14. Global Human Rabies Vaccines Revenue Market Share by Type (2017-2022)
Figure 15. Human Rabies Vaccines Consumed in Pre-Exposure Prophylaxis
Figure 16. Global Human Rabies Vaccines Market: Pre-Exposure Prophylaxis (2017-2022) & (K Units)
Figure 17. Human Rabies Vaccines Consumed in Post-Exposure Prophylaxis
Figure 18. Global Human Rabies Vaccines Market: Post-Exposure Prophylaxis (2017-2022) & (K Units)
Figure 19. Global Human Rabies Vaccines Sales Market Share by Application (2017-2022)
Figure 20. Global Human Rabies Vaccines Revenue Market Share by Application in 2021
Figure 21. Human Rabies Vaccines Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Human Rabies Vaccines Revenue Market Share by Company in 2021
Figure 23. Global Human Rabies Vaccines Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Human Rabies Vaccines Revenue Market Share by Geographic Region in 2021
Figure 25. Global Human Rabies Vaccines Sales Market Share by Region (2017-2022)
Figure 26. Global Human Rabies Vaccines Revenue Market Share by Country/Region in 2021
Figure 27. Americas Human Rabies Vaccines Sales 2017-2022 (K Units)
Figure 28. Americas Human Rabies Vaccines Revenue 2017-2022 ($ Millions)
Figure 29. APAC Human Rabies Vaccines Sales 2017-2022 (K Units)
Figure 30. APAC Human Rabies Vaccines Revenue 2017-2022 ($ Millions)
Figure 31. Europe Human Rabies Vaccines Sales 2017-2022 (K Units)
Figure 32. Europe Human Rabies Vaccines Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Human Rabies Vaccines Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Human Rabies Vaccines Revenue 2017-2022 ($ Millions)
Figure 35. Americas Human Rabies Vaccines Sales Market Share by Country in 2021
Figure 36. Americas Human Rabies Vaccines Revenue Market Share by Country in 2021
Figure 37. United States Human Rabies Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Human Rabies Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Human Rabies Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Human Rabies Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Human Rabies Vaccines Sales Market Share by Region in 2021
Figure 42. APAC Human Rabies Vaccines Revenue Market Share by Regions in 2021
Figure 43. China Human Rabies Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Human Rabies Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Human Rabies Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Human Rabies Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Human Rabies Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Human Rabies Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Human Rabies Vaccines Sales Market Share by Country in 2021
Figure 50. Europe Human Rabies Vaccines Revenue Market Share by Country in 2021
Figure 51. Germany Human Rabies Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Human Rabies Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Human Rabies Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Human Rabies Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Human Rabies Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Human Rabies Vaccines Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Human Rabies Vaccines Revenue Market Share by Country in 2021
Figure 58. Egypt Human Rabies Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Human Rabies Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Human Rabies Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Human Rabies Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Human Rabies Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Human Rabies Vaccines in 2021
Figure 64. Manufacturing Process Analysis of Human Rabies Vaccines
Figure 65. Industry Chain Structure of Human Rabies Vaccines
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...